| Net loss | -9.42M |
| Non-cash stock-based compensation | 3.96M |
| Depreciation and amortization | 10.8K |
| Amortization of premium/discount on investment securities, convertible notes and debt discount and issuance costs | |
| Write-off of debt related costs | |
| Impairment charge/(gain), net on investment securities and ARS put | |
| (Gain)/loss on disposal of assets | |
| Impairment of sublease | |
| Prepaid expenses and other assets | 60.67K |
| Accounts payable, accrued expenses, income taxes payable and deferred rent | |
| Accrued compensation and related expenses | |
| Restricted assets | |
| Net cash used in operating activities | |
| Cash paid for acquired business, net of acquired cash | |
| Purchases of investment securities | |
| Maturities or sales of investment securities | |
| Acquisition of property and equipment | -66.84K |
| Proceeds from sales of property and equipment | |
| Net cash provided by (used in) investing activities | |
| Net proceeds from the sale of common stock | |
| Net proceeds from the sale of warrants | |
| Sale of preferred stock, net of issuance costs | |
| Proceeds from ARS loan | |
| Repayments of ARS loan | |
| Proceeds from debt issuance, net | |
| Repayments of debt | |
| Proceeds from conversion of convertible notes | |
| Purchase of treasury stock, net of employee stock purchases | |
| Net cash (used in) provided by financing activities | |
| Net (decrease) increase in cash and cash equivalents | 2.9M |
| Cash and cash equivalents, beginning of period | 22.08M |
| Cash and cash equivalents, end of period | 24.97M |
| Conversion of convertible preferred stock into common stock upon IPO | |
| Restricted assets, cash unrestricted upon conversion of convertible notes | |
| Income taxes paid | 6.04K |
| Interest paid | |